BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 7, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2004
View Archived Issues
CHMP adopts extension of indication for Schering-Plough HCV products
Read More
Merck researchers describe new anti-HIV vaccines
Read More
New Eg5 kinesin inhibitors developed by AstraZeneca researchers
Read More
Novel JNK inhibitors and their use reported by Eisai
Read More
Agents combining antimitotic, antiangiogenic and PDE4 activity claimed by Celgene
Read More
Novel MCH receptor antagonists prepared and tested at Schering-Plough
Read More
Roche claims new 5-HT6 receptor ligands for cognitive disorders, psychosis, etc.
Read More
Urea-based glycogen phosphorylase a inhibitors newly developed at Aventis
Read More
New 5-HT2C receptor modulators under study at GSK
Read More
Series B financing at Othera to accelerate pipeline development
Read More
Japanese approval sought for Advate
Read More
Final approval and first-to-file status for Alpharma's gabapentin
Read More
Phase II study for Levulan Kerastick in acne
Read More
Spiriva approved for Japanese import
Read More
Dacogen MAA accepted for review
Read More
Japanese approval for Trisenox
Read More
Urocortin 2 evaluated in new phase I study
Read More
Evoclin approved for acne vulgaris
Read More
Velac NDA accepted for filing
Read More
Ivax signs U.S. agreement for citicoline
Read More
Emerging companies showcased at the 12th Annual BioPartnering Europe conference: Austrianova
Read More
Emerging companies showcased at the 12th Annual BioPartnering Europe conference: Ionix
Read More
Nociceptin opioid receptor antagonist may be useful in the management of addictive disorders
Read More
Improved nucleoside triphosphate analogue promising against HCV infection
Read More
Reversal of multidrug resistance in tumor cells by FG-020318
Read More
TAS-108 evaluated in advanced breast cancer
Read More
Fampridine-SR active in multiple sclerosis
Read More
Studies reveal teriflunomide efficacy in treating multiple sclerosis
Read More
Superoxide-driven nitration of endogenous MnSOD critical in NMDA-mediated hyperalgesia
Read More